Literature DB >> 17419081

Strabismus might be a risk factor for amblyopia recurrence.

Josefin Nilsson1, Melanie Baumann, Johan Sjöstrand.   

Abstract

BACKGROUND: Previous reports have suggested that one-fourth of amblyopic subjects present with recurrence of amblyopia even after successful primary treatment. Risk factors for amblyopia recurrence are insufficiently studied, but therapy weaning has recently been suggested as a method for reducing the risk of recurrence.
METHODS: In the second phase of a prospective study examining the results of treatment for amblyopia, all 35 children with successful primary amblyopia treatment were put on maintenance therapy. Maintenance therapy consisted of low-intensity patching, atropine, or blurring filter, and all children were regularly examined up to at least 8 years of age. Mean age at start of maintenance therapy was 4.3 years (range, 2-7 years).
RESULTS: Of the 35 cases with successful primary treatment, 6 cases deteriorated >or=0.2 logMAR, which was considered recurrence of amblyopia. Two of these cases had a second recurrence. Notably, all six subjects presenting with recurrence had microstrabismus. This finding was just outside statistical significance at the 95% confidence level (p = 0.06), but the sample size was small. All but one of the recurrences appeared within 6 months after successful primary treatment. Age at successful primary treatment or initial interocular difference of visual acuity did not affect the risk of recurrence.
CONCLUSIONS: Recurrence of amblyopia occurred in 17% of patients despite maintenance therapy and was associated with microstrabismus. The majority of recurrences occurred within the first 6 months after primary treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17419081     DOI: 10.1016/j.jaapos.2007.01.117

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  7 in total

Review 1.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

2.  The Need for a Unified Protocol for Termination of Amblyopia Treatment.

Authors:  Mahmoud M Nassar; Fiona Campbell Mitchell
Journal:  Br Ir Orthopt J       Date:  2018-04-24

3.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

4.  Factors associated with recurrence of amblyopia on cessation of patching.

Authors:  Jonathan M Holmes; Michele Melia; Yasmin S Bradfield; Oscar A Cruz; Brian Forbes
Journal:  Ophthalmology       Date:  2007-03-23       Impact factor: 12.079

5.  Fixational eye movements abnormalities and rate of visual acuity and stereoacuity improvement with part time patching.

Authors:  Matteo Scaramuzzi; Jordan Murray; Paolo Nucci; Aasef G Shaikh; Fatema F Ghasia
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

6.  Evaluation of 'vision screening' program for three to six-year-old children in the Republic of Iran.

Authors:  Rajiv Khandekar; Noa Parast; Ashraf Arabi
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

Review 7.  Management of amblyopia in pediatric patients: Current insights.

Authors:  Sagnik Sen; Pallavi Singh; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 3.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.